Company / Capital Expenditures
Bausch Health Companies Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$397.0M
FY2025
5-year range
$269.0M / $397.0M
FY2021-FY2025
Trend
+17.8%
vs FY2024
Sector context
#13 of 194
Health Care
What the data says
Among 194 Health Care companies, Bausch Health Companies Inc. is in the top 7% for capital expenditures. Capital Expenditures has fluctuated over the past 10 years, ranging from $157M in FY2020 to $397M in FY2025.
Based on SEC 10-K filings.
$397M in FY2025 with a 5-year CAGR of +20.4%. Top quartile in the Health Care sector.
Improved from $269M to $397M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +9.5%
- 5-Year CAGR
- +20.4%
- 10-Year CAGR
- -
Sector benchmark
+237.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +20.4%, indicating consistent growth.
- In FY2025, capital expenditures increased 17.8% year-over-year.
- Ranks #13 out of 194 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $397.0M | +17.8% |
| FY2024 | $337.0M | +25.3% |
| FY2023 | $269.0M | -10.9% |
| FY2022 | $302.0M | +12.3% |
| FY2021 | $269.0M | +71.3% |
| FY2020 | $157.0M | -8.2% |
| FY2019 | $171.0M | -27.2% |
| FY2018 | $235.0M | +37.4% |
| FY2017 | $171.0M | -27.2% |
| FY2016 | $235.0M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026